David Hare Articles
![PCSK9 inhibition in heart failure](https://www.pcsk9forum.org/wp-content/uploads/david-hare-2.png)
PCSK9 inhibition in heart failure
Prof David Hare University of Melbourne and Director of Secondary Prevention Programs at Austin Health, Melbourne, Australia Whether lowering LDL cholesterol with a PCSK9 inhibitor on top of statin therapy confers benefit – or harm – in heart failure patients was tested in this latest…
read more »![Depression, Cardiovascular Disease and Adherence](https://www.pcsk9forum.org/wp-content/uploads/david-hare-1-1.png)
Depression, Cardiovascular Disease and Adherence
David Hare & Samia R Toukhsati, University of Melbourne, Australia This editorial discusses the interrelationship between cardiovascular disease and depression and poses the question: Is depression a key modulator of patient adherence and clinical outcome? “Depression” can refer to anything from feeling transiently unhappy through…
read more »![An update on cardiovascular disease, depression and adherence](https://www.pcsk9forum.org/wp-content/uploads/Screen-Shot-2017-11-07-at-10.26.08-1.png)
An update on cardiovascular disease, depression and adherence
Reports from the 7th Expert Meeting of PCSK9 Forum David Hare
read more »![Many key barriers are amenable to change; new strategies are needed](https://www.pcsk9forum.org/wp-content/uploads/hare-150x150.png)
Many key barriers are amenable to change; new strategies are needed
General considerations: David L. Hare, University of Melbourne Australia
read more »